As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
L’expertise universitaire, l’exigence journalistique
Articles sur Wegovy
Affichage de 21 à 28 de 28 articles
Some pharmacies are selling ‘generic’ semaglutide online, despite the drug still being under patent protection.
Obesity is said to cost the NHS an estimated £6 billion a year.
Anti-obesity medications are becoming the go-to treatment for weight loss. But drugs alone may not provide the same benefits as lifestyle choices like exercise and a healthy diet.
The much-discussed weight-loss jab may be good for treating Britain’s biggest killer: dementia. Trials are underway.
Ozempic uses semaglutide to mimic the role of a hormone naturally produced by the body to create feelings of fullness. Certain foods can do the same thing.
Overweight or obese patients who meet certain criteria will soon be able to access the much talked about weight-loss jab.
You’ve probably heard of the drug semaglutide or Ozempic, the diabetes medication being used for weight loss. So what are the risks and benefits? And who should have access to it?
Les contributeurs les plus fréquents
-
Associate Professor of Metabolic Medicine, University of Surrey
-
General Practitioner, PhD Candidate, Bond University
-
Lecturer, Pharmacy, Aston University
-
Associate Professor of Gastroenterology, School of Medicine, University of Washington
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Professor and Director Academic Excellence, Macquarie University
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Career Development Fellow, University of Oxford
-
Lecturer Pharmacy Practice, University of Sydney
-
Professor of Exercise Science and Interim Dean of the School of Health Sciences, College of Charleston
-
Senior Lecturer in Physiology, Anglia Ruskin University
-
DPhil Candidate, Alzheimer's, University of Oxford
-
Postdoctoral Researcher, School of Public Health, University College Cork
-
Emeritus Professor of Reproductive and Periconceptual Medicine, The Robinson Research Institute, University of Adelaide
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
